The molecular genetics of the tauopathies.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Experimental Gerontology

• Publication date

  2000-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0531-5565(00)00114-5PMID 10959034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein

  2000cited by this paper
• Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

  1999cited by this paper
• Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.

  1999cited by this paper
• Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

  1999cited by this paper
• FTDP‐17 tau mutations decrease the susceptibility of tau to calpain I digestion

  1999cited by this paper
• Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation

  1999cited by this paper
• Effects of frontotemporal dementia FTDP‐17 mutations on heparin‐induced assembly of tau filaments

  1999cited by this paper
• 5′ Splice Site Mutations in tau Associated with the Inherited Dementia FTDP-17 Affect a Stem-Loop Structure That Regulates Alternative Splicing of Exon 10*

  1999cited by this paper
• Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.

  1999cited by this paper
• Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease.

  1999cited by this paper
• Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations

  1999cited by this paper
• High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

  1999cited by this paper
• Clinical and Genetic Aspects of Progressive Supranuclear Palsy

  1998cited by this paper
• A nucleated assembly mechanism of Alzheimer paired helical filaments.

  1998cited by this paper
• Tau is a candidate gene for chromosome 17 frontotemporal dementia

  1998cited by this paper
• Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies

  1998cited by this paper
• Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

  1998cited by this paper
• Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.

  1998cited by this paper
• Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly

  1998cited by this paper
• Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau

  1998cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Neurodegenerative diseases with cytoskeletal pathology: A biochemical classification

  1997cited by this paper
• Genetic evidence for the involvement of τ in progressive supranuclear palsy

  1997cited by this paper
• Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference

  1997cited by this paper
• Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes

  1995cited by this paper
• Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform.

  1995cited by this paper
• Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

  1989cited by this paper
• Developmentally regulated expression of specific tau sequences.

  1989cited by this paper
• The microtubule binding domain of tau protein.

  1989cited by this paper

• Biomolecular phase separation of microtubule-associated protein Tau and its role in the genesis of Brain Disorders.

  2025cites this paper
• The potential of mulberry (Morus alba L.) leaf extract against pro-aggregant tau-mediated inflammation and mitochondrial dysfunction.

  2025cites this paper
• Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward

  2022cites this paper
• Phytochemical Based Modulation of Endoplasmic Reticulum Stress in Alzheimer's Disease.

  2022cites this paper
• Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

  2022cites this paper
• Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors

  2019cites this paper
• Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.

  2019cites this paper
• Detection of somatic variants from genomic data and their role in neurodegenerative diseases

  2019cites this paper
• Microtubule density and landing rate as parameters to analyze tau protein in the MT-kinesin "gliding" assay

  2017cites this paper
• Human TTBK1, TTBK2 and MARK1 kinase toxicity in Drosophila melanogaster is exacerbated by co-expression of human Tau

  2017influential citation
• Rehabilitation Strategies Progressive Supranuclear Palsy: Disease Profile and

  2016cites this paper
• Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models

  2016cites this paper
• Genetic Investigations of Sporadic Inclusion Body Myositis and Myopathies with Structural Abnormalities and Protein Aggregates in Muscle

  2016cites this paper
• On-chip microtubule gliding assay for parallel measurement of tau protein species.

  2016cites this paper
• Sporadic inclusion body myositis: the genetic contributions to the pathogenesis

  2014cites this paper
• Neurodegenerative Disorders: Dementia and Parkinsonism, Lumping Together or Splitting Apart?

  2014cites this paper
• TOC1: a valuable tool in assessing disease progression in the rTg4510 mouse model of tauopathy.

  2014cites this paper
• Thinking laterally about neurodegenerative proteinopathies.

  2013cites this paper
• Long-Term Exercise Training for an Individual With Mixed Corticobasal Degeneration and Progressive Supranuclear Palsy Features: 10-Year Case Report Follow-up

  2013cites this paper
• Using Drosophila to study the contribution of human kinases to tau toxicity

  2012cites this paper
• Hyperbaric Oxygen Therapy and Alzheimer ’ s Disease

  2011cites this paper
• [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].

  2009cites this paper
• Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies

  2008cites this paper
• Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets

  2008cites this paper
• 33Neurodegenerative Diseases and Single

  2008cites this paper
• Familial Neurodegenerative Diseases and Single Nucleotide Polymorphisms

  2008cites this paper
• Cdk5 Regulates the Phosphorylation of Tyrosine 1472 NR2B and the Surface Expression of NMDA Receptors

  2008cites this paper
• Progressive supranuclear palsy.

  2007cites this paper
• FRONTOTEMPORAL DEMENTIA

  2007cites this paper
• Role of tau in Alzheimer's dementia and other neurodegenerative diseases

  2007cites this paper
• Novel subtractive transcription-based amplification of mRNA (STAR) method and its application in search of rare and differentially expressed genes in AD brains

  2006cites this paper
• Progressive supranuclear palsy: disease profile and rehabilitation strategies.

  2006cites this paper
• Disease modifying therapy for AD? 1

  2006cites this paper
• Frontotemporal dementia--a brief review.

  2006cites this paper
• Progressive supranuclear palsy and corticobasal degeneration: Lumping versus splitting

  2005cites this paper
• Neurodegenerative Diseases: Alzheimer's disease: overview

  2005cites this paper
• Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy

  2004cites this paper
• Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau.

  2004cites this paper
• Epidemiology of non-AD dementias

  2004cites this paper
• A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10

  2004cites this paper
• Familial frontotemporal dementia: from gene discovery to clinical molecular diagnostics.

  2003cites this paper
• Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia.

  2003cites this paper
• Mutation Screening of the MAPT and STH Genes in Polish Patients with Clinically Diagnosed Frontotemporal Dementia

  2003cites this paper
• Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies.

  2003cites this paper
• The Slow Axonal Transport of the Microtubule-Associated Protein Tau and the Transport Rates of Different Isoforms and Mutants in Cultured Neurons

  2002cites this paper
• Pharmacotherapy for Alzheimer's disease: progress and prospects.

  2002cites this paper
• Progressive supranuclear palsy: where are we now?

  2002cites this paper
• Molecular genetics of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).

  2002cites this paper
• Presenile dementia syndromes: an update on taxonomy and diagnosis

  2002cites this paper
• Transgenic Mice Model in Alzheimer's Disease

  2002cites this paper
• In-vitro-Analyse der biochemischen und strukturellen Auswirkungen von Mutationen im Tau-Protein bei frontotemporalen Demenzen : Implikationen für die Alzheimer-Krankheit

  2002cites this paper
• Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes.

  2002cites this paper
• P301L tauopathy: confocal immunofluorescence study of perinuclear aggregation of the mutated protein.

  2002cites this paper
• Preclinical and clinical challenges in the development of disease-modifying therapies for Alzheimer's disease.

  2001cites this paper
• Recent advances in the understanding of tau protein and movement disorders

  2001cites this paper
• Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation.

  2001cites this paper
• Selective Deposition of Mutant Tau in the FTDP‐17 Brain Affected by the P301L Mutation

  2001cites this paper